» Articles » PMID: 2415198

Plasma Amino Acids in Relation to Cerebrospinal Fluid Monoamine Metabolites in Schizophrenic Patients and Healthy Controls

Overview
Journal Br J Psychiatry
Specialty Psychiatry
Date 1985 Sep 1
PMID 2415198
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Compared to healthy controls, unmedicated schizophrenic patients had significantly higher plasma concentrations of taurine, methionine, valine, isoleucine, leucine, phenylalanine, and lysine. Except for taurine, these amino acids share the L-transport system for neutral amino acids. In the patients, homovanillic (HVA) acid levels in CSF were decreased and the plasma levels of the amino acids competing with tyrosine and tryptophan for transport into the brain, were all negatively correlated to the CSF concentrations of HVA and 5-HIAA. These findings could be explained by a change in the affinity of the L-system or by a decrease in its overall capacity in schizophrenia. Raised plasma levels of the competing amino acids may limit the brain uptake of tyrosine, leading to a diminished dopamine turnover, and resulting in a compensatory development of supersensitive dopamine receptors.

Citing Articles

An exploratory study of metabolomics in endogenous and cannabis-use-associated psychotic-like experiences in adolescence.

Kurkinen K, Karkkainen O, Lehto S, Luoma I, Kraav S, Kivimaki P Transl Psychiatry. 2024; 14(1):466.

PMID: 39511135 PMC: 11543670. DOI: 10.1038/s41398-024-03163-9.


Potential diagnostic biomarkers for schizophrenia.

Yue W, Huang H, Duan J Med Rev (2021). 2023; 2(4):385-416.

PMID: 37724326 PMC: 10388817. DOI: 10.1515/mr-2022-0009.


Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis.

Romer T, Jeppesen R, Christensen R, Benros M Mol Psychiatry. 2023; 28(6):2277-2290.

PMID: 37169812 DOI: 10.1038/s41380-023-02059-2.


Metabolomics mapping changed after olanzapine therapy in drug-naive schizophrenia patients-the significant impact of gene polymorphisms.

Karahalil B, Elkama A, Ak M, Nemutlu E Toxicol Res (Camb). 2022; 11(3):547-556.

PMID: 35782649 PMC: 9244978. DOI: 10.1093/toxres/tfac034.


A Selective Review of the Excitatory-Inhibitory Imbalance in Schizophrenia: Underlying Biology, Genetics, Microcircuits, and Symptoms.

Liu Y, Ouyang P, Zheng Y, Mi L, Zhao J, Ning Y Front Cell Dev Biol. 2021; 9:664535.

PMID: 34746116 PMC: 8567014. DOI: 10.3389/fcell.2021.664535.